Stockscreener 앱 받기
33.35
1.83%
0.60
시간 외 거래:
33.35
Immunocore Holdings Plc Adr 주식(IMCR)의 최신 뉴스
Columbia Banking System, Inc. (NASDAQ:COLB) Given Average Recommendation of “Hold” by Analysts - Defense World
TVTX Stock Falls as FDA Extends Review Timeline for Filspari sNDA - Finviz
BEAM Outlines Key Strategic & Pipeline Goals for 2026, Stock Rises - Yahoo Finance
Immunocore (NASDAQ:IMCR) Upgraded at Zacks Research - Defense World
Immunocore (IMCR) upgraded to strong buy: Here's what you should know - MSN
Immunocore outlines 2026 strategy at J.P. Morgan conference - Investing.com
Immunocore (IMCR) Upgraded to Strong Buy: Here's What You Should Know - Yahoo Finance
Immunocore (NASDAQ:IMCR) Shares Gap UpWhat's Next? - MarketBeat
UBS assumes coverage on Immunocore stock with Buy rating, $55 target - Investing.com
UBS assumes coverage on Immunocore stock with Buy rating, $55 target By Investing.com - Investing.com South Africa
Immunocore Holdings PLC Sponsored ADR (NASDAQ:IMCR) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Immunocore Holdings PLC Sponsored ADR (NASDAQ:IMCR) Given Consensus Rating of “Moderate Buy” by Brokerages - Defense World
Hudson Bay Capital Management LP Sells 49,382 Shares of Immunocore Holdings PLC Sponsored ADR $IMCR - MarketBeat
Immunocore Holdings PLC Sponsored ADR $IMCR Shares Bought by Frazier Life Sciences Management L.P. - MarketBeat
Bellevue Group AG Increases Stake in Immunocore Holdings PLC Sponsored ADR $IMCR - MarketBeat
Eschler Asset Management LLP Invests $1.26 Million in Immunocore Holdings PLC Sponsored ADR $IMCR - MarketBeat
1,024,288 Shares in Immunocore Holdings PLC Sponsored ADR $IMCR Purchased by BVF Inc. IL - MarketBeat
Immunocore Holdings PLC Sponsored ADR $IMCR Stock Position Lowered by Armistice Capital LLC - MarketBeat
Immunocore Holdings plc (IMCR) Asserts Pipeline Development and Strong Commercial Performance - Finviz
Immunocore (NASDAQ:IMCR) Sets New 52-Week High – Here’s Why - Defense World
Immunocore (NASDAQ:IMCR) Reaches New 1-Year HighHere's What Happened - MarketBeat
Schroder Investment Management Group Boosts Stock Holdings in Immunocore Holdings PLC Sponsored ADR $IMCR - MarketBeat
Immunocore stock hits 52-week high at 40.71 USD By Investing.com - Investing.com India
Immunocore stock hits 52-week high at 40.71 USD - Investing.com
Immunocore (NASDAQ:IMCR) Shares Gap DownHere's What Happened - MarketBeat
Immunocore Holdings stock hits 52-week high at $40.53 - Investing.com
Immunocore Holdings stock hits 52-week high at $40.53 By Investing.com - Investing.com South Africa
Immunocore announces board and executive departures with no reported disagreements - Investing.com
Immunocore (NASDAQ:IMCR) Sets New 1-Year HighStill a Buy? - MarketBeat
Immunocore Holdings PLC Sponsored ADR (NASDAQ:IMCR) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Immunocore Holdings PLC Sponsored ADR (NASDAQ:IMCR) Given Average Rating of “Moderate Buy” by Brokerages - Defense World
Immunocore (NASDAQ:IMCR) Reaches New 52-Week HighWhat's Next? - MarketBeat
Immunocore stock hits 52-week high at 39.5 USD - Investing.com
Immunocore at Jefferies Conference: Strategic Expansion and Innovation By Investing.com - Investing.com South Africa
Immunocore at Jefferies Conference: Strategic Expansion and Innovation - Investing.com
A Fresh Look at Immunocore Holdings (NasdaqGS:IMCR) Valuation After Positive Phase 1 Data for HBV Therapy - Sahm
Acadian Asset Management LLC Acquires 72,355 Shares of Immunocore Holdings PLC Sponsored ADR $IMCR - MarketBeat
Fiera Capital Corp Purchases 7,924 Shares of Immunocore Holdings PLC Sponsored ADR $IMCR - MarketBeat
Positive Hepatitis B Trial Data Might Change the Case for Investing in Immunocore Holdings (IMCR) - Sahm
Immunocore reports promising data for HBV treatment candidate By Investing.com - Investing.com South Africa
Immunocore reports promising data for HBV treatment candidate - Investing.com
Immunocore presents Phase 1 data for hepatitis B candidate at AASLD’s The Liver Meeting - GlobeNewswire Inc.
Immunocore (IMCR) Reports Q3 Earnings: What Key Metrics Have to Say - Yahoo Finance
Brokerages Set Immunocore Holdings PLC Sponsored ADR (NASDAQ:IMCR) Target Price at $60.89 - Defense World
Recursion Pharmaceuticals to Report Q3 Earnings: What's in the Cards? - sharewise.com
State of New Jersey Common Pension Fund D Purchases New Position in Immunocore Holdings PLC Sponsored ADR $IMCR - MarketBeat
Y Intercept Hong Kong Ltd Makes New $1.62 Million Investment in Immunocore Holdings PLC Sponsored ADR $IMCR - MarketBeat
Immunocore Holdings PLC Sponsored ADR (NASDAQ:IMCR) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Immunocore (NASDAQ:IMCR) Sees Unusually-High Trading VolumeHere's What Happened - MarketBeat
H.C. Wainwright reaffirms Buy rating on Immunocore stock at $100 target - Investing.com
TD Asset Management Inc Sells 9,590 Shares of Immunocore Holdings PLC Sponsored ADR $IMCR - MarketBeat
Immunocore Holdings PLC Sponsored ADR (NASDAQ:IMCR) Given Average Rating of "Hold" by Brokerages - MarketBeat
4.73%
0.92%
자본화:
|
볼륨(24시간):